Zobrazeno 1 - 3
of 3
pro vyhledávání: '"L K, Najvar"'
Publikováno v:
Medical mycology. 36(3)
BMS 181184 (BMS), an analogue of pradimicin, was administered intravenously to neutropenic mice infected with either a fluconazole-susceptible or a fluconazole-resistant clinical isolate of Candida tropicalis. BMS prolonged survival at doses3 mg kg -
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::49aa65165be833396cb7269cd27e1e37
https://pubmed.ncbi.nlm.nih.gov/9776832
https://pubmed.ncbi.nlm.nih.gov/9776832
Publikováno v:
Antimicrobial agents and chemotherapy. 41(5)
This study elucidates the role of combined fluconazole and flucytosine as therapy for cryptococcosis in the murine model of meningitis. Three strains of Cryptococcus neoformans for which the range of fluconazole MICs was wide--2 microg/ml (susceptibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83c709d89b02aee28dea3e9e04c081cd
https://pubmed.ncbi.nlm.nih.gov/9145879
https://pubmed.ncbi.nlm.nih.gov/9145879
Publikováno v:
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology. 35(3)
Albendazole has in vitro activity against Cryptococcus neoformans and reduced in vitro activity for albendazole when compared with Candida albicans. The major metabolite of albendazole, albendazole sulphoxide showed no in vitro activity against isola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e504deb83ca567e313065ff8b4baad1e
https://pubmed.ncbi.nlm.nih.gov/9229330
https://pubmed.ncbi.nlm.nih.gov/9229330